Journals / Güncel Pediatri / 2008 / Cilt: 6 - Sayı: 3

Steven’s Johnson syndrome and toxic epidermal necrolysis in children

Çocuklarda Steven’s Johnson sendromu ve toksik epidermal nekroliz

Pages
104–110
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Although drug reactions were seen less frequently in children compared to adults, it must be taken into consideration that there is the risk of developing severe drug reactions like SJS and TEN in children who have been using such drugs for a long time or using multipl drugs for extended period

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The aim of this study was to consider clinical features, laboratory findings, treatment alternatives, complications and responsible agents of Steven’s Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) in childhood.Materials and Method: The patients who were diagnosed with Steven’s Johnson syndrome (SJS) or Toxic Epidermal Necrolysis (TEN) and followed by Department of Dermatology, Division of Pediatric Neurology and Division of Pediatric Allergy of Uludag University Faculty of Medicine, between 2000-2008 were evaluated retrospectively.
📊
Key Findings & Data:Results: Records of 14 patients (7 females/7 males) were examined.
💡
Conclusion & Impact:Conclusion: Although drug reactions were seen less frequently in children compared to adults, it must be taken into consideration that there is the risk of developing severe drug reactions like SJS and TEN in children who have been using such drugs for a long time or using multipl drugs for extended period
🔬Design:Research Article
📍Scope:2000-2008 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: The aim of this study was to consider clinical features, laboratory findings, treatment alternatives, complications and responsible agents of Steven’s Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) in childhood.Materials and Method: The patients who were diagnosed with Steven’s Johnson syndrome (SJS) or Toxic Epidermal Necrolysis (TEN) and followed by Department of Dermatology, Division of Pediatric Neurology and Division of Pediatric Allergy of Uludag University Faculty of Medicine, between 2000-2008 were evaluated retrospectively. Results: Records of 14 patients (7 females/7 males) were examined. Nine of the patients had SJS, 2 had SJS-TEN overlap syndrome and the rest 3 had TEN. Nine patients had history of using drugs for epilepsy and the others for anxiety, tooth abscess, cryptic tonsillitis, otitis media and bronchiolitis. Eleven of the patients (78.5%) had multiple drug intake. In 7 patients (50%) Lamotrigine (4 of 7 patients was also taken Valproic acid) and in other patients oxcarbamazepine, azytromicine, phenytoin, imipramine, cefuroxime axetil, ciprofloxacin, ceftriaxone were responsible for SJS and TEN. Twelve patients were treated with systemic corticosteroids and 2 with intravenous immunoglobulin. All of the patients were cured. Conclusion: Although drug reactions were seen less frequently in children compared to adults, it must be taken into consideration that there is the risk of developing severe drug reactions like SJS and TEN in children who have been using such drugs for a long time or using multipl drugs for extended period

Özet

Amaç: Steven’s Johnson Sendromu (SJS) ve Toksik Epidermal Nekroliz (TEN) tanısı almış çocuk hastalarda klinik bulgular, sorumlu etkenler, laboratuvar sonuçları, komplikasyonlar ve tedavi seçeneklerinin gözden geçirilmesi amaçlandı. Gereç ve Yöntem: Uludağ Üniversitesi Tıp Fakültesi Dermatoloji Anabilim Dalı, Çocuk Nöroloji Bilim Dalı ve Çocuk Alerji Bilim Dalı’na 2000-2008 yılları arasında başvuran SJS ve TEN tanısı almış olan hastalar retrospektif olarak incelenmiştir. Bulgular: Toplam 14 hastanın (7’si kız ve 7’si erkek) kayıtları incelendi. Hastaların 9’u SJS, 2’si SJS-TEN overlap sendrom, 3’ü TEN idi. Dokuz hastanın epilepsi tanısı ile, diğer hastaların anksiyete, diş apsesi, kriptik tonsillit, otitis media ve bronşit tanıları ile ilaç kullanım öyküleri mevcuttu. Hastaların 11’inde (%78,5) çoklu ilaç kullanımı bulunmaktaydı. SJS/TEN etyolojisinde 7 hastada (%50) Lamotrijin (7 hastanın 4'ünde ek olarak Valproik asit kullanımı vardı) diğer hastalarda Okskarbamazepin, Azitromisin, Fenitoin, İmipramin, Sefuroksim aksetil, Siprofloksasin, Seftriakson kullanımının sorumlu olduğu düşünüldü. Oniki hastaya sistemik kortikosteroid, 2 hastaya intravenöz immünglobulin tedavisi uygulanmıştı ve hastaların tümünde tam iyileşme görüldüğü saptandı. Sonuç: İlaç reaksiyonları çocuklarda erişkinlere oranla daha az görülmekle birlikte uzun süreli ve çoklu ilaç kullanımı olan çocuk hastalarda, SJS ve TEN gibi şiddetli ilaç reaksiyonlarının gelişme riski göz önünde bulundurulmalıdır.

🔖

Cite This Article

CANITEZ, Y., ÖZDEMİR, Ö., TURAN, H., VATANSEVER, S., SARICAOĞLU, H. (2022). Steven’s Johnson syndrome and toxic epidermal necrolysis in children. Güncel Pediatri, Cilt: 6 - Sayı: 3, 104–110. https://ajindex.com/articles/528107

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129: 92-6
  2. Forman R, Koren G, Shear NH. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience. Drug Safety 2002; 25: 965-72
  3. Huff JC, Weston WL, Tonnesen MG. Erythema multiforme: a critical review of characteristics, diagnostic criteria and causes. J Am Acad Dermatol 1983; 8: 763-75
  4. Shin HT, Change MW. Drug eruptions in children. Probl Dermatol 2002; 14: 147-82
  5. Dore J, Salisbury RE. Morbidity and mortality of mucocutaneous diseases in the pediatric population at a tertiary care center. J Burn Care Res 2007; 28: 865-70
  6. Friedmann PS, Leew MS, Friedmann AC, Barnetson RSC. Mechanisms in cutaneous drug hypersensitivity reactions. Clin Exp Allergy 2003; 33: 861-72
  7. Fritsch PO, Sidoroff A. Drug-induced Stevens-Jonson syndrome/toxic epidermal necrolysis. Am J Clin Dermatol 2000; 1: 349-60
  8. Paul C, Wolkenstein P, Adle H, et al. Apopitosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol 1996; 134: 710-4
  9. Letko E, Papaliodis DN, Papaliodis GN, Yasinse JD, Ahmed AR, Foster S. Stevens-Johnson syndrome and toxic epidermal necrolysis: A review of the literature. Ann Allergy Asthma Immunol 2005; 94: 419-36
  10. Paquet P, Pierard GE. Erythema multiforme and toxic epidermal necrolysis: A comparative study. Am J Dermatopathol 1997; 19: 127-32
  11. Shear NH, Spielberg SP, Grant DM, Tang BK, Kalow W. Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med 1986; 105: 179-84
  12. Ruiz-Maldonado R. Acute disseminated epidermal necrosis types 1,2 and 3: Study of sixty cases. J Am Acad Dermatol 1985; 13: 623-35
  13. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994; 331: 1272-85
  14. French EL, Prins C. Toxic Epidermal Necrolysis. In: Bolognia JL, Jorizzo JL, Rapini RP, editors. Dermatology. St Louis: Mosby; 2003. p. 323-31
  15. Spies M, Sanford AP, Aili Low JF, Wolf SE, Herndon DN. Treatment of extensive toxic epidermal necrolysis in children. Pediatrics 2001; 108: 1162-8
  16. Thomé-Souza S, Freitas A, Fiore LA, Valente KD. Lamotrigine and valproate: efficacy of co-administration in a pediatric population. Pediatr Neurol 2003; 28: 360-4
  17. Leaute-Labreze C, Lamireau T, Chawki